MCG for Risk Stratifications of Patients With Chest Pain - Trial NCT06316011
Access comprehensive clinical trial information for NCT06316011 through Pure Global AI's free database. This phase not specified trial is sponsored by Qilu Hospital of Shandong University and is currently Not yet recruiting. The study focuses on Acute Coronary Syndrome. Target enrollment is 3620 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Qilu Hospital of Shandong University
Timeline & Enrollment
N/A
Mar 20, 2024
Aug 31, 2024
Primary Outcome
Efficacy of MCG for the detection and risk stratification in patients with chest pain
Summary
This prospective cohort study is aimed at identification and risk stratification of patients
 who have symptoms of acute chest pain suspected with acute coronary syndrome ๏ผACS๏ผ using
 Magnetocardiography ๏ผMCG๏ผ.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06316011
Device Trial